Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Spectroscopy in Children and Adolescents With Bipolar Disorder

This study has been completed.
Janssen Pharmaceutica
Information provided by (Responsible Party):
Joseph Biederman, MD, Massachusetts General Hospital Identifier:
First received: September 13, 2005
Last updated: June 12, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2005
  Primary Completion Date: November 2005 (Final data collection date for primary outcome measure)